158 related articles for article (PubMed ID: 34539981)
21. Phenotypic and functional heterogeneity of CD169⁺ and CD163⁺ macrophages from porcine lymph nodes and spleen.
Alvarez B; Martínez P; Yuste M; Poderoso T; Alonso F; Domínguez J; Ezquerra A; Revilla C
Dev Comp Immunol; 2014 May; 44(1):44-9. PubMed ID: 24291017
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of CD169-positive macrophages in various tumors: a meta-analysis.
Kong W; Wei M; Liu R; Zhang J; Wang X
Bioengineered; 2021 Dec; 12(1):8505-8514. PubMed ID: 34607536
[TBL] [Abstract][Full Text] [Related]
23. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone.
Steiniger B; Barth P; Herbst B; Hartnell A; Crocker PR
Immunology; 1997 Oct; 92(2):307-16. PubMed ID: 9415041
[TBL] [Abstract][Full Text] [Related]
24. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
[TBL] [Abstract][Full Text] [Related]
25. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes.
Gray EE; Friend S; Suzuki K; Phan TG; Cyster JG
PLoS One; 2012; 7(6):e38258. PubMed ID: 22675532
[TBL] [Abstract][Full Text] [Related]
26. CD169
Nagata M; Ishizaka K; Asano T
Res Rep Urol; 2023; 15():1-7. PubMed ID: 36660299
[TBL] [Abstract][Full Text] [Related]
27. CD169
Briem O; Källberg E; Kimbung S; Veerla S; Stenström J; Hatschek T; Hagerling C; Hedenfalk I; Leandersson K
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831605
[TBL] [Abstract][Full Text] [Related]
28. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.
Kumamoto K; Tasaki T; Ohnishi K; Shibata M; Shimajiri S; Harada M; Komohara Y; Nakayama T
Front Oncol; 2021; 11():636751. PubMed ID: 33816277
[TBL] [Abstract][Full Text] [Related]
29. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas.
Marmey B; Boix C; Barbaroux JB; Dieu-Nosjean MC; Diebold J; Audouin J; Fridman WH; Mueller CG; Molina TJ
Hum Pathol; 2006 Jan; 37(1):68-77. PubMed ID: 16360418
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
31. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
Black LV; Saunderson SC; Coutinho FP; Muhsin-Sharafaldine MR; Damani TT; Dunn AC; McLellan AD
Immunol Cell Biol; 2016 May; 94(5):430-8. PubMed ID: 26647968
[TBL] [Abstract][Full Text] [Related]
32. CD169
Grabowska J; Lopez-Venegas MA; Affandi AJ; den Haan JMM
Front Immunol; 2018; 9():2472. PubMed ID: 30416504
[TBL] [Abstract][Full Text] [Related]
33. A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.
Li C; Luo X; Lin Y; Tang X; Ling L; Wang L; Jiang Y
PLoS One; 2015; 10(10):e0141817. PubMed ID: 26509874
[TBL] [Abstract][Full Text] [Related]
34. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
[TBL] [Abstract][Full Text] [Related]
35. CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients.
Zhang J; Xu J; Zhang RX; Zhang Y; Ou QJ; Li JQ; Jiang ZZ; Wu XJ; Fang YJ; Zheng L
Oncoimmunology; 2016 Jul; 5(7):e1177690. PubMed ID: 27622027
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer associated CD169
Gunnarsdottir FB; Briem O; Lindgren AY; Källberg E; Andersen C; Grenthe R; Rosenqvist C; Millrud CR; Wallgren M; Viklund H; Bexell D; Johansson ME; Hedenfalk I; Hagerling C; Leandersson K
Front Immunol; 2023; 14():1180209. PubMed ID: 37404831
[TBL] [Abstract][Full Text] [Related]
37. Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.
Herzog S; Fragkou PC; Arneth BM; Mkhlof S; Skevaki C
Front Med (Lausanne); 2022; 9():979373. PubMed ID: 36213653
[TBL] [Abstract][Full Text] [Related]
38. Melanoma growth and lymph node metastasis is independent of host CD169 expression.
Muhsin-Sharafaldine MR; Saunderson SC; Dunn AC; McLellan AD
Biochem Biophys Res Commun; 2017 May; 486(4):965-970. PubMed ID: 28359758
[TBL] [Abstract][Full Text] [Related]
39. CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid.
Asano K; Kikuchi K; Tanaka M
J Biochem; 2018 Aug; 164(2):77-85. PubMed ID: 29905851
[TBL] [Abstract][Full Text] [Related]
40. Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone.
Habbeddine M; Verthuy C; Rastoin O; Chasson L; Bebien M; Bajenoff M; Adriouch S; den Haan JMM; Penninger JM; Lawrence T
Cell Rep; 2017 Nov; 21(9):2515-2527. PubMed ID: 29186688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
